Palisade Bio (PALI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov11

Palisade Bio released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0 (forecast USD -0.2733)

04:00

Palisade Bio released FY2025 9 Months Earnings on November 10 (EST), actual revenue USD 0, actual EPS USD -1.429

04:00

Oct20

Palisade Bio announces first patients treated with PALI-2108 drug

12:52

Oct13

Palisade Bio Acquires Canadian Patent and Advances PALI-2108 Clinical Trials

12:46

Aug12

Palisade Bio released FY2025 Semi-Annual earnings on August 11, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.0453

03:00

Palisade Bio released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5803 (forecast USD -0.56)

03:00

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.868 M, EPS -0.3837

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.784 M, EPS -0.5803

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -2.23 M, EPS -0.465

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More